CODX: Prakiraan rega marang bathi Co-Diagnostics

Co-Diagnostics, Inc. (CODX) combines bioethics with environmental safety, although the post-pandemic slump and FDA regulations are forcing a diversification of diagnostics. The company's forward P/E NTM reveals hidden trading dynamics, where the value of 0.00 serves as the baseline indicator for the current valuation. Financial results are based on the licensing of molecular technologies and the sale of PCR systems to medical centers.

Kapitalisasi marang proyeksi bathi: codiagnostics.com (CODX) kanggo 04.07.2022 - 14.11.2026

Rincian analitis lan laporan data perusahaan CoDx (CODX)

- nilai saham lan prakiraan konsensus rega:

Bagan rega Co-Diagnostics|CODX - Bagan rega target

- informasi kapitalisasi pasar:

Biji pasar Co-Diagnostics Inc|CODX - Total Nilai Perusahaan

- statistik nilai buku emiten:

Aset Bersih saben Siji Saham Co-Diagnostics|CODX - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku codiagnostics.com|CODX - Gunggung Aset Perusahaan

- data tingkat utang lan likuiditas finansial:

Utang marang Ekuitas Co-Diagnostics, Inc.|CODX - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang modal Co-Diagnostics, Inc.|CODX - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Co-Diagnostics Inc|CODX - Utang jangka dawa|Kewajiban jangka cendhak perusahaan Co-Diagnostics|Rasio cepet codiagnostics.com

- indikator profitabilitas perusahaan lan kelipatan valuasi:

CODX - Bathi perusahaan|Proyeksi bathi mangsa ngarep Co-Diagnostics, Inc.|CODX - Periode bali modal bisnis|Pangali Forward P/E Co-Diagnostics Corp|CODX - Pangali PEG|Pangali EV/EBITDA Co-Diagnostics Inc|CODX - Bathi operasional sadurunge potongan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Co-Diagnostics|CODX - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan codiagnostics.com|CODX - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Co-Diagnostics, Inc.

- data pendapatan lan penerimaan dodolan:

CODX - Pendapatan reged perusahaan|Volume dodolan mangsa ngarep perusahaan Co-Diagnostics|CODX - Kapitalisasi marang volume dodolan|Multiplikator Forward P/S Co-Diagnostics Inc

Analisis fundamental perusahaan:CODX Co-Diagnostics

Forward P/E measures the current share price relative to projected net income, allowing investors to assess the market discount or premium for future business growth. By analyzing the expected price-to-earnings ratio of Co-Diagnostics, Inc. (CODX), one can observe how the risk of declining revenue from diagnostic tests impacts the valuation of Co-Diagnostics, Inc. (CODX) stability amidst fierce competition.

Pesaing Co-Diagnostics, Inc. (CODX)